Farnesyl pyrophosphate synthase (FPPS) plays an important role in the mevalonate pathway, and the FPPS inhibitor alendronate can alleviate diabetes-induced atherosclerosis and inhibit high glucose-induced proliferation of VSMCs in vitro. The gene discussed is FDPS; the disease is atherosclerosis.